January 2026
The global type 1 diabetes market size is estimated at USD 37.60 billion in 2025 and is projected to hit around USD 79.14 billion by 2035 with a CAGR of 7.73%.
September 2026
The type 2 diabetes market size reached USD 43.29 billion in 2026, with leading type 2 diabetes market companies including medtronic plc, abbott laboratories, sanofi sa, dexcom, astrazeneca.
June 2026
The global Type 2 diabetes management market explores the growth of therapeutic, monitoring and digital solutions driven by rising global prevalence, obesity and lifestyle-related risks.
July 2026
The global diabetes drug market size was calculated at USD 75.09 billion in 2025 and is projected to hit around USD 138.83 billion by 2035 with a CAGR of 6.34%.
June 2026
The digital diabetes management market size was recorded at USD 37.89 billion in 2025 and is projected to cross around USD 192.91 billion by 2035, at a CAGR of 17.67%
September 2026
The global S1P receptor modulator drugs market size is estimated to hit around USD 6.96 billion by 2035 increasing from USD 3.42 billion in 2026, with a CAGR of 8.22%.
September 2026
The global diabetes devices market size accounted for USD 37.98 billion in 2026 and is projected to hit around USD 73.43 billion by 2035, growing at a CAGR of 7.61%.
September 2026
The global coenzyme Q10 market size was evaluated at USD 878.19 million in 2026 and is predicted to surpass around USD 1,847.29 million by 2034, at a notable CAGR of 9.68%.
September 2026
The 1,5-hexadiene market was valued at USD 195.00 million in 2026, with leading companies including Evonik Industries, INEOS, Chevron Phillips Chemical, Shell Chemicals.
September 2026
The global diabetes care devices market size was evaluated at USD 68.57 billion in 2025 and is predicted to hit around USD 125.03 billion by 2035, growing at a CAGR of 6.19%.
September 2026
The global triazine type UV absorber market size is estimated to hit around USD 2.90 billion by 2034 increasing from USD 1.51 billion in 2026, with a CAGR of 8.53%.
July 2026
The global K-12 furniture market size was estimated at USD 6.64 billion in 2026 and is expected to hit around USD 10.4 billion by 2035, growing at a CAGR of 5.11% from 2026 to 2035.
July 2026
The global K 12 instructive toy market size is estimated to hit around USD 185.51 billion by 2035 increasing from USD 85.28Â billion in 2026, with a CAGR of 9.05%.
July 2026
The global GLP-1 market size was evaluated at USD 58.40 billion in 2025 and is predicted to hit around USD 212.73 billion by 2035, growing at a CAGR of 13.80%.
July 2026
The global GLP-1 analogues market size was evaluated at USD 66.48 billion in 2025 and is predicted to hit around USD 1,062.90 billion by 2035, growing at a CAGR of 31.94%
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The diabetes management technologies market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
June 2026
The Australia GLP-1 receptor agonist market size was valued at USD 652.07 million in 2026 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.
June 2026
The global PD-1 inhibitor drugs market size was estimated at USD 48.69 billion in 2025 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
June 2026
The global prediabetes market size is calculated at USD 322.14 million in 2025 and is estimated to hit around USD 635.6 million by 2035 with a CAGR of 7.03%.
June 2026
The global hemoglobin A1c testing devices market size is estimated to hit around USD 4.72 billion by 2035 from USD 2.69 billion in 2026, with a CAGR of 6.48%.
February 2026
The global diabetes associated ophthalmic treatment market size was evaluated at USD 7.34 billion in 2026 and is predicted to hit around USD 12.65 billion by 2035, growing at a CAGR of 6.24%.
February 2026
The global obesity GLP-1 market size was evaluated at USD 8.21 billion in 2025 and is predicted to hit around USD 66.57 billion by 2035, growing at a CAGR of 23.28%.
January 2026
The pet diabetes care devices market size was estimated at USD 2.58 billion in 2025 and is projected to worth around USD 5.54 billion by 2035, with a CAGR of 6.87%.
November 2025
The global alpha-1 antitrypsin deficiency augmentation therapy market size is estimated to hit around USD 2.96 billion by 2034 from USD 1.84 billion in 2026, at a CAGR of 6.14%.
August 2025
The global diabetes nutrition market size is estimated to hit around USD 25.22 billion by 2034 increasing from USD 12.64 billion in 2024, with a CAGR of 7.15%
September 2026
The vascular patches market is forecast to increase from USD 547.00 million in 2025 to USD 1,051.15 million by 2035, at a CAGR of 6.75%.
September 2026
The fiber cement market was valued at USD 21.80 billion in 2026, with leading companies including Akzo Nobel NV, Canfor Corporation, Central Fiber LLC.
September 2026
The ultrafast rectifiers market was valued at USD 4.83 billion in 2026, with leading companies including STMicroelectronics, Diodes Incorporated, Fairchild Semiconductor.
September 2026
The global stem cell transplantation market growth is driven by rising cancer cases, advances in regenerative medicine, and increasing stem cell research.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com